EARNEST Partners’s Teladoc Health TDOC Stock Holding History

EARNEST Partners’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-39	Closed	-$725	–	995
2023 Q3	$725	Hold	39	–	–	﹤0.01%	1095
2023 Q2	$987	Hold	39	–	–	﹤0.01%	1074
2023 Q1	$1.01K	Hold	39	–	–	﹤0.01%	1061
2022 Q4	$922	Hold	39	–	–	﹤0.01%	1088
2022 Q3	$1K	Hold	39	–	–	﹤0.01%	1086
2022 Q2	$1K	Hold	39	–	–	﹤0.01%	1105
2022 Q1	$3K	Hold	39	–	–	﹤0.01%	970
2021 Q4	$4K	Hold	39	–	–	﹤0.01%	927
2021 Q3	$5K	Hold	39	–	–	﹤0.01%	867
2021 Q2	$6K	Hold	39	–	–	﹤0.01%	818
2021 Q1	$7K	Hold	39	–	–	﹤0.01%	746
2020 Q4	$8K	Hold	39	–	–	﹤0.01%	696
2020 Q3	$9K	Buy	+39	New	+$8.26K	﹤0.01%	603

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EARNEST Partners's TDOC Position: Q4 2023 in Review

EARNEST Partners sold out of Teladoc Health (TDOC) in Q4 2023, closing a stake of 39 shares — an estimated $725 sold.

EARNEST Partners first reported a position in TDOC in Q3 2020 and held it in 13 quarters. The position peaked at $9K in Q3 2020. 435 funds tracked by Wall St. Rank hold TDOC as of Q4 2023.

EARNEST Partners reported no remaining Teladoc Health position as of Q4 2023 after selling out during the quarter.
EARNEST Partners sold 39 Teladoc Health shares in Q4 2023, an estimated $725.
EARNEST Partners first reported a position in Teladoc Health in Q3 2020 and held it in 13 quarters.
EARNEST Partners's Teladoc Health position peaked at $9K in Q3 2020.
435 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.